Biofil Chemicals & Pharmaceuticals Ltd.

Financial

	Biofil Chem & Pharma	Makers Laboratories	Bharat Immunological
Operational Metrics
Financials
5 yr Average ROE	5.42 %	-2.26 %	-29.83 %
5yr average Equity Multiplier	2.09	2.42	3.08
5yr Average Asset Turnover Ratio	0.96	0.68	0.61
5yr Avg Net Profit Margin	2.86 %	-1.82 %	-18.38 %
Price to Book	5.27	1.37	1.3
P/E	181.69	19.44	0.0
5yr Avg Cash Conversion Cycle	65.55 Days	81.6 Days	206.63 Days
Inventory Days	25.38 Days	108.24 Days	125.06 Days
Days Receivable	244.02 Days	69.51 Days	61.4 Days
Days Payable	179.27 Days	109.89 Days	117.81 Days
5yr Average Interest Coverage Ratio	21.93	3.06	-2.32
5yr Avg ROCE	7.69 %	4.88 %	-44.64 %
5yr Avg Operating Profit Margin	4.5 %	7.75 %	-18.7 %
5 yr average Debt to Equity	0.04	0.25	0.71
5yr CAGR Net Profit	-10.11 %	80.14 %	23.51 %
5yr Average Return on Assets	2.72 %	-0.95 %	-10.1 %
Shareholdings
Promoter Holding	46.82 %	61.27 %	59.25 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	2.9 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Biofil Chem & Pharma	Makers Laboratories	Bharat Immunological
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 87.6 Chemicals 12.4 Services 0 Chemicals 0 Generic Formulation 0 BIBSANIT 0 BIB VIT 0 Zinc Tablets 0 Oral Polio Vaccine 0	Product Wise Break-Up Formulation 39.53 Services 7.75 Oral Polio Vaccine 0 BIBSANIT 0 Pharmaceuticals 0 BIB VIT 0 Chemicals 52.71 Zinc Tablets 0 Others 0.01	Product Wise Break-Up Generic Formulation 0 Services 0 Oral Polio Vaccine 100.0 BIBSANIT 0 Pharmaceuticals 0 BIB VIT 0 Chemicals 0 Zinc Tablets 0
Operating Profit Break-Up	Operating Profit Break-Up Chemicals 91.76 Pharmaceuticals 8.24 Chemical 0 Pharmaceutical 0	Operating Profit Break-Up Chemicals 0 Pharmaceuticals 0 Chemical 19.07 Pharmaceutical 80.93	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise Pharma 57.82 Chemical 42.18	-	-